Overall conditional survival in 2-year survivors after autologous BMT in childhood, by primary diagnosis
| Overall survival at each additional 5 y after BMT, y . | Entire cohort . | Primary diagnosis . | ||||||
|---|---|---|---|---|---|---|---|---|
| ALL . | AML . | HL . | NHL . | Neuroblastoma . | Other malignant disease* . | |||
| N . | % . | % . | % . | % . | % . | % . | % . | |
| 2+ | 280 | 81.2 | 67.4 | 95.6 | 86.7 | 90.3 | 78.5 | 71.9 |
| 5+ | 207 | 90.9 | 89.7 | 95.4 | 88.7 | 96.3 | 89.4 | 88.4 |
| 10+ | 162 | 95.3 | 96.2 | 97.5 | 95.3 | 82.0 | 97.6 | 100.0 |
| 15+ | 196 | 99.3 | 100.0 | 100.0 | 96.6 | 100.0 | 100.0 | 100.0 |
| Overall survival at each additional 5 y after BMT, y . | Entire cohort . | Primary diagnosis . | ||||||
|---|---|---|---|---|---|---|---|---|
| ALL . | AML . | HL . | NHL . | Neuroblastoma . | Other malignant disease* . | |||
| N . | % . | % . | % . | % . | % . | % . | % . | |
| 2+ | 280 | 81.2 | 67.4 | 95.6 | 86.7 | 90.3 | 78.5 | 71.9 |
| 5+ | 207 | 90.9 | 89.7 | 95.4 | 88.7 | 96.3 | 89.4 | 88.4 |
| 10+ | 162 | 95.3 | 96.2 | 97.5 | 95.3 | 82.0 | 97.6 | 100.0 |
| 15+ | 196 | 99.3 | 100.0 | 100.0 | 96.6 | 100.0 | 100.0 | 100.0 |
Includes 25 Ewing sarcomas, 11 Wilms tumor, 9 CNS tumors, 4 desmoplastic small round cell tumors, 6 soft tissue sarcoma, 1 ovarian tumor, 1 hepatoblastoma, and 1 multiple myeloma.